| CARIS LIFE SCIENCES |
| USA |
| Gesundheit |
| US1421521071 / A41A14 |
| 49J (Frankfurt) / CAI (NASDAQ) |
| FRA:49J, ETR:49J, 49J:GR, NASDAQ:CAI |
| - |
| https://www.carislifescie.. |
|
Caris Life Sciences is a leading AI-driven precision medicine company that transforms healthcare through comprehensive molecular profiling and advanced machine learning. The company specializes in analyzing cancer at the molecular level by performing..
>Volltext.. |
| 4600.32 Mio. EUR |
| 4286.95 Mio. EUR |
| 695.41 Mio. EUR |
| 58.02 Mio. EUR |
| -58.31 Mio. EUR |
| -1.64 EUR |
| 366.26 Mio. EUR |
| 683.22 Mio. EUR |
| 64.61 Mio. EUR |
| 6.29 |
| 73.61% |
| 78.71% |
| - |
| - |
| - |
| - |
| CARIS LIFE |
| 08.04.26 |
|